The Sixth CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science Into Survival will take place in autumn 2022 in New York City.
New York Academy of Sciences’ ninth annual convening of immuno-oncology experts across academia and industry sharing cutting-edge discoveries
Join CRI for an in-depth look into the newest and most exciting approach to vaccination in our lifetime… mRNA vaccines.
2020 International Cancer Immunotherapy Conference in New York City is canceled due to the COVID-19 pandemic.
The Symposium will bring together 15 accomplished faculty mentors to share their discoveries and research career experience in cancer immunology with 40 promising young scientists.
How science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19. Live stream event with Drs. Carl H. June, Miriam Merad, and E. John Wherry; moderated by Matthew Herper, STAT
The New York Academy of Sciences annual two-day meeting convenes top experts in tumor immunology, cancer genetics and computational biology.
The Fifth CRI-CIMT-EATI-AACR CICON takes place September 25-28, 2019, at Espace Grand Arche de la Défense in Paris, France.
Hosted by the Cancer Research Institute this intimate, invitation-only event for media and health care investment analysts will explore what’s next in the IO field.
This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).
Drs. Stefani Spranger and Elsa Anagnostou recap highlights relating to myeloid cells, tumor heterogeneity, and preclinical models from Day 2 of of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).